1-4 of 4
Gomes da Silva Maria, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World

Catherine Thieblemont, MD PhD, Loïc Chartier, Ulrich Dührsen, Prof, MD PhD, Umberto Vitolo, MD, Sally F Barrington, Prof, MD PhD, Laetitia Vercellino, Jan Zaucha, MDPhD, Inês Patrocinio Carvalho, Gomes da Silva Maria, MD PhD, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, MD PhD, Alina Berriolo-Riedinger, Rene-Olivier Casasnovas, MD, Andreas Hüttmann, MD, Hajira Ilyas, George Mikhaeel, Prof, MD PhD, Joel Dunn, Anne Ségolène Cottereau, MD, Christine Schmitz, MD, Joseph N. Paulson, Tina G Nielsen, Michel Meignan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-136544
Published: 2020
Journal Articles

Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL)

Simone Ferrero, MD, Daniele Grimaldi, MD, Elena Arrigoni, Gian Maria Zaccaria, PhD, Beatrice Alessandria, Elisa Genuardi, Gabriele De Luca, Marco Ghislieri, Alice Di Rocco, Alessandro Re, MD, Vittorio Stefoni, MD PhD, Federica Cavallo, Carola Boccomini, MD, Monica Balzarotti, Vittorio Ruggero Zilioli, MD, Gomes da Silva Maria, MD PhD, Luca Arcaini, Anna Lia Molinari, MD, Filippo Ballerini, MD, Andres JM Ferreri, MD, Benedetta Puccini, Giuseppe A. Palumbo, MD PhD, Sara Galimberti, MD PhD, Sergio Cortelazzo, MD, Antonello Di Paolo, Marco Ladetto, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-134875
Published: 2020
Journal Articles

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Gerhard Held, MD, Roch Houot, MD PhD, Abraham Avigdor, MD, Marc André, Anna Dabrowska-Iwanicka, Ulrich Jaeger, MD, Sanne Tonino, MD PhD, Marek Trneny, MD prof, Gomes da Silva Maria, MD PhD, Philippe Gaulard, MD PhD, Thierry Jo Molina, MD PhD, Andreas Rosenwald, MD, Grzegorz Rymkiewicz, Thierry Fest, Karin Tarte, PhD, Markus Loeffler, MD, Marita Ziepert, PhD, Bettina Altmann, PhD, Viola Poeschel, MD, Corinne Haioun, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5311.
https://doi.org/10.1182/blood-2019-129362
Published: 2019
Journal Articles

Validation of the PRIMA-Prognostic Index for Patients Treated with Rituximab Plus Chemotherapy and Refinement of Prognostic Parameters for Patients on Rituximab Plus Lenalidomide in the Phase III Relevance Trial

Edith Julia, Nathan H Fowler, MD, Emmanuel Bachy, MD PhD, Pierre Feugier, MD PhD, Reda Bouabdallah, Herve Tilly, MD PhD, M. Lia Palomba, MD, Christophe Fruchart, MD, Edward N. Libby, III, MD, Rene-Olivier Casasnovas, MD, Ian W. Flinn, MD PhD, Corinne Haioun, MD PhD, Herve Maisonneuve, MD, Loic Ysebaert, MD PhD, Nancy L. Bartlett, MD, Kamal Bouabdallah, MD, Pauline Brice, Vincent Ribrag, MD, Nicolas Daguindau, MD, Steven Le Gouill, Gian-Matteo Pica, MD, Alejandro Martín, MD PhD, Armando Lopez-Guillermo, Jean-Francois Larouche, MD, Kiyoshi Ando, Gomes da Silva Maria, MD PhD, Marc André, Ka Lung Wu, MD, Laurie H Sehn, MD, Kensei Tobinai, MD PhD, Guillaume Cartron, Richard Delarue, Myron Czuczman, Luc Xerri, MD PhD, Gilles A. Salles, MD PhD, Franck Morschhauser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1524.
https://doi.org/10.1182/blood-2019-129024
Published: 2019